Our 2023 Sustainability Report is here! Once again, it's a testament to the progress we're making toward some of our most important goals. ♻️↗️🌍 A few key highlights: • SBTi Membership: We've joined the Science Based Targets initiative, aligning ourselves with rigorous targets to combat global warming. • EcoVadis Platinum: Our continued commitment has earned us Platinum status from EcoVadis, placing us in the top 1% of companies for sustainability efforts. • Supply Chain Responsibility: We're proactively preparing to uphold the high standards of environmental and social responsibility throughout our #supplychain. This report reflects our unwavering belief: Economic growth, ambitious environmental goals and also social initiatives like education can be achieved together. We're determined to be a leader in environmentally conscious pharmaceutical manufacturing, and to reach that goal in a way that builds a healthier planet – now and in the future. Dive into the full report below and share your thoughts! What environmental innovations stand out to you? https://lnkd.in/eP54WrBJ #Sustainability #CDMO #Pharma #ResponsibleBusiness #SustainabilityReport
Vetter Pharma
Pharmaceutical Manufacturing
Ravensburg, Baden-Württemberg 23,452 followers
Your partner in aseptic filling and packaging
About us
We turn active ingredients into medicine. As one of the leading pharmaceutical service providers for the aseptic manufacture of injectable medicines, we are a global player – and a family business. Together with our 6,000 employees, we help improve the lives of people around the world. We combine tradition and innovation in a job that has meaning. Ravensburg is where our roots are. We make a significant contribution to reliably supplying patients with medicines from our state-of-the-art production sites in Europe and the United States. We work hand in hand with pharmaceutical and biotechnology companies of all sizes, accompanying them on their journey to help those who are affected with their treatment of cancer, multiple sclerosis, and other diseases – from active ingredient development all the way to its delivery in people. With success comes responsibility. Teamwork, openness, and commitment: These qualities are important to us. At Vetter, we are sustainably helping to shape the future. We fully support personal and professional development – to build a strong team in which everyone can develop their skills, and in which every contribution counts. And for those who rely on us. Find out more about our company at www.vetter-pharma.com/ Privacy Notice: https://www.vetter-pharma.com/en/privacy-notice Imprint: https://www.vetter-pharma.com/en/imprint
- Website
-
https://www.vetter-pharma.com
External link for Vetter Pharma
- Industry
- Pharmaceutical Manufacturing
- Company size
- 5,001-10,000 employees
- Headquarters
- Ravensburg, Baden-Württemberg
- Type
- Privately Held
- Founded
- 1950
- Specialties
- Biopharmaceuticals, Pharmaceuticals, Drug manufacturing, Clinical development, Commercial production, Lyophilization, Packaging, Contract Manufacturing, CDMO, Clinical Manufacturing, Prefilled Syringes, Commercial Manufcacturing, and Fill Finish
Locations
-
Primary
Schützenstraße 87
Ravensburg, Baden-Württemberg 88212, DE
Employees at Vetter Pharma
Updates
-
Look out #Boston, we’re on our way! Our bags are packed and our enthusiasm is high. We’re ready to explore the Hub's historic charm and dive into TIDES USA in Boston! From May 15-17, we’ll be showcasing our expertise in aseptic filling for oligonucleotides and peptides, and eager to connect with some of the best and brightest minds in the industry. Want to talk about how Vetter’s experience can elevate your drug development journey? You know where to find us! 📍 Hynes Convention Center, Boston, MA 🗓️ May 15-17, 2024 🤝 Booth #731 Swing by and let’s unlock the potential of your parenteral oligonucleotide and peptide therapeutics together. We’d also love all your tips on where to find the best Lobster Roll... #TIDESUSA #therapeuticinnovation
-
Developing a parenteral therapy in France? Our colleague Barbara Ruggiero highlights a valuable opportunity to save costs and extend your R&D budget! 🙌🏼 🇫🇷 Thanks to our CIR accreditation from the French Ministry for Higher Education and Research, French drug developers who outsource R&D activities to Vetter can capture generous tax incentives with a big impact on development program budgets. Reach out to Barbara to learn how she and her team can help you navigate the application process! #RnD #drugdevelopment
Business Development Manager Europe - Clinical manufacturing of injectables at Vetter Pharma International
Chez Vetter, nous savons que la R&D est l’une des lignes budgétaires la plus importante pour nos clients. C’est pourquoi nous nous efforçons d’être le partenaire qui maximise leur investissement dans un remplissage aseptique de haute qualité. Pour les développeurs de médicaments en France, ce partenariat avec Vetter peut vous donner accès au Crédit Impot Recherche du Ministère de l’Enseignement Supérieur et de la Recherche. Le CIR est une opportunité de taille pour les sociétés investissant dans la recherche et développement et qui offre des économies substantielles pour financer leurs efforts d’innovation. Sous-traiter les activités de développement de produits injectables à Vetter peut aider les sociétés françaises à optimiser leur budget R&D, accélérer leur développement et étendre leurs projets. Si vous souhaitez en savoir davantage, n’hésitez pas à nous contacter à tous moments. Mon équipe et moi-même serons ravis de partager notre connaissance du CIR pour vous soutenir dans cette démarche.
-
Part IV of taking you on #AerialView tours around our production facilities! Our Vetter Development Service site in Rankweil, Austria, specializes in clinical manufacturing. It has a dedicated team of 66 employees who focus on processes and technologies for preclinical and clinical Phase I and II as well as preparation for phase III and commercial manufacturing. #VetterPharma #ClinicalManufacturing
-
Part III of taking you on #AerialView tours around our production facilities! Our Erlen site, west of Ravensburg, serves as logistics and visual inspection hub. Equipped with state-of-the-art technology – for example a fully automated material warehouse or several automatic visual inspection machines – as well as nine rooms for manual visual inspection and so much more, it's a site with a dedicated team of over 850 employees. #VetterPharma #VisualInspection #Logistics
-
Curious about the latest in pharmaceutical manufacturing? Our very own Nils Bischoff, Product & Service Manager at Vetter, shares insights into tackling today’s manufacturing challenges, equipment advances, and areas of production innovation in an interview with Contract Pharma. He emphasizes the importance of process reliability, product safety, and security of supply in navigating evolving regulatory landscapes. Read the full interview here: https://lnkd.in/eWzqWbxb #PharmaceuticalManufacturing #CDMO #VetterPharma
-
Part II of taking you on #AerialView tours around our production facilities. At our site in Mariatal, south of #Ravensburg, we're proud to have an aseptic production plant with six filling lines, a packaging site with eight automated packaging lines, five rooms for manual packaging, and a visual inspection center with 14 rooms for manual visual inspection. It's a site with around 1.800 skilled employees. #VetterPharma #AsepticManufacturing #SecondaryPackaging #VisualInspection
-
Over the next few weeks, we'll take you on #aerialview trips around our state-of-the-art production facilities! Let's start with our Schuetzenstrasse site on the outskirts of our hometown Ravensburg! In the video, you see our headquarters and one of our aseptic production plants: a site with eight filling lines and around 2.200 dedicated employees. Take a look at our new production building, where further filling lines are being built! 🏗 🏗 🏗 #AsepticManufacturing #ManufacturingExcellence
-
We’re pleased to announce that we have successfully placed a promissory note loan totaling €325 million! Due to the significant demand, we were able to increase the originally planned issuance volume of €100 million substantially. This loan, with maturities of 5, 7, and 10 years in fixed and variable tranches, represents a significant step in strengthening our independent long-term corporate and investment strategy. Our aim is to further expand our capabilities, to be a trusted partner to our customers, and ultimately to reliably supply life-saving medications to patients worldwide. Many thanks to our investors and partners for their trust and support on this journey! #CDMO #CorporateFinance #BusinessGrowth
-
🌍 Today, on #WorldHealthDay, we want to raise awareness of health as a fundamental human right. This year's theme, "My health, my right", expresses the belief that everyone deserves access to quality healthcare, regardless of their background or circumstances. It's a reminder that health should not just be a privilege, but a basic right for all! Let's create a healthier and more inclusive world for everyone! You can find more information about the World Health Organization's campaign here: https://lnkd.in/e52RwFP5 #VetterPharma #WorldHealthDay #WHO